Characteristic | n |
Age (y) | 68.8 (50–83) |
PSA (ng/mL) | 5.67 (0.2–18,000) |
Injected dose (MBq) | 151 (97–236) |
Classification | |
PC-proven | 18 |
By histology | 7 |
By therapy response | 11 |
Other entity–proven | 8 |
Non–small cell lung cancer | 7 |
Tuberculosis | 1 |
PC highly probable | 15 |
Unclear | 4 |
Data in parentheses are ranges.